Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT04730583 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Neurofibroma

Interventions

DRUG: Kybella
DEVICE: 1064nm laser
DEVICE: 755nm Alexandrite Laser

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]